The FDA has expanded the indication for TMS for patients as young as 15 years of age.Benjamin GreenzweigAug 15, 20241 min readUpdated: Nov 25, 2024Can A New FDA-Cleared Treatment Help Address Depression in Adolescents? Read Now on Vouge
Comments